Format

Send to

Choose Destination
World J Gastroenterol. 2014 Dec 7;20(45):16795-810. doi: 10.3748/wjg.v20.i45.16795.

Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Author information

1
Valerio Giannelli, Vincenza Di Gregorio, Michela Giusto, Manuela Merli, Gastroenterology Department of Clinical Medicine, Sapienza University of Rome, 00185 Rome, Italy.

Abstract

Liver disease is associated with qualitative and quantitative changes in the intestinal microbiota. In cirrhotic patients the alteration in gut microbiota is characterized by an overgrowth of potentially pathogenic bacteria (i.e., gram negative species) and a decrease in autochthonous familiae. Here we summarize the available literature on the risk of gut dysbiosis in liver cirrhosis and its clinical consequences. We therefore described the features of the complex interaction between gut microbiota and cirrhotic host, the so called "gut-liver axis", with a particular attention to the acquired risk of bacterial translocation, systemic inflammation and the relationship with systemic infections in the cirrhotic patient. Such knowledge might help to develop novel and innovative strategies for the prevention and therapy of gut dysbiosis and its complication in liver cirrhosis.

KEYWORDS:

Bacterial overgrowth; Bacterial translocation; Cirrhosis; Dysbiosis; Gut; Infection; Inflammation; Lactulose; Liver; Portal hypertension; Rifaximine

PMID:
25492994
PMCID:
PMC4258550
DOI:
10.3748/wjg.v20.i45.16795
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
Loading ...
Support Center